The STICH trial showed that CABG surgery does not necessarily improve cardiovascular outcomes in patients with coronary artery disease and left ventricular dysfunction who are receiving optimal medical therapy. However, surgical revascularization should still be considered if the coronary artery disease is severe and viable myocardium can be identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Velazquez, E. J. et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N. Engl. J. Med. 364, 1607–1616 (2011).
Bonow, R. O. et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N. Engl. J. Med. 364, 1617–1625 (2011).
Fang, J. C. Underestimating medical therapy for coronary disease ... again. N. Engl. J. Med. 364, 1671–1673 (2011).
Boden, W. E. et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356, 1503–1516 (2007).
Velazquez, E. J. et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J. Thorac. Cardiovasc. Surg. 134, 1540–1547 (2007).
Jones, R. H. et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N. Engl. J. Med. 360, 1705–1717 (2009).
Jones, R. H. et al. STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. J. Am. Coll. Cardiol. 56, 490–498 (2010).
Eagle, K. A. et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1999 guidelines for coronary artery bypass graft surgery). J. Am. Coll. Cardiol. 44, 1146–1154 (2004).
Acknowledgements
M. J. Mack was a local principal investigator for the Medical City Dallas site in the STICH trial, but was not involved in the analysis of data or in writing the trial report.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Mack, M. How should the STICH trial results affect clinical practice?. Nat Rev Cardiol 8, 427–428 (2011). https://doi.org/10.1038/nrcardio.2011.103
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2011.103
